Marcosian mode: Duterte threatens to arrest water execs ‘one night’ LIVE: Sinulog 2020 Grand Parade 787 earthquakes recorded in 24 hours due to restive Taal Volcano Missile-capable frigate BRP Jose Rizal inches closer to entering PH Navy’s fleet Filipinos turn Taal Volcano ash, plastic trash into bricks PLAY LIST 01:40Filipinos turn Taal Volcano ash, plastic trash into bricks01:32Taal Volcano watch: Island fissures steaming, lake water receding02:14Carpio hits red carpet treatment for China Coast Guard02:56NCRPO pledges to donate P3.5 million to victims of Taal eruption00:56Heavy rain brings some relief in Australia02:37Calm moments allow Taal folks some respite Malacañang open to creating Taal Commission I mean who doesn’t like pizza 🍕!!!! 🤷🏾♂️. 😂😂😂. Ain’t that right @BlazePizza?!?! https://t.co/udZyBCGRUc— LeBron James (@KingJames) July 11, 2017James even appeared as an undercover employee named “Ron” in a viral promotional video for the company. Khristian Ibarrola /raADVERTISEMENT IT happens: Facebook sorry for Xi Jinping’s name mistranslation “LeBron helps us punch in terms of our brand awareness well above our weight,” Blaze Pizza CEO Jim Mizes told Forbes.com.The four-time NBA MVP first invested in the restaurant in 2012, and currently owns 10 percent of the company, the report said.FEATURED STORIESSPORTSEnd of his agony? SC rules in favor of Espinosa, orders promoter heirs to pay boxing legendSPORTSRedemption is sweet for Ginebra, Scottie ThompsonSPORTSMayweather beats Pacquiao, Canelo for ‘Fighter of the Decade’In 2015 James shunned a reported $14-million endorsement deal with fast-food chain McDonald’s to be able to join Blaze Pizza’s marketing campaigns.Since then, “The King” has promoted the innovative pizza place on his social media accounts. Don’t miss out on the latest news and information. MOST READ LATEST STORIES Sports Related Videospowered by AdSparcRead Next Duterte’s ‘soft heart’ could save ABS-CBN, says election lawyer Duterte’s ‘soft heart’ could save ABS-CBN, says election lawyer Padda fights off back pains to guide Adamson to first PVL win LeBron James #23 of the Cleveland Cavaliers JASON MILLER/Getty Images/AFPLeBron James has certainly earned enough throughout his career to last multiple lifetimes, but he continues to make smart investments with his money.Among his successful ventures is the emerging build-your-own pizza chain “Blaze Pizza,” which recently opened its 200th branch in just four years—making it the fastest-growing restaurant in the US.ADVERTISEMENT End of his agony? SC rules in favor of Espinosa, orders promoter heirs to pay boxing legend View comments
Tamir KalifaStudents on the campus of the University of Texas at Austin.After subtracting student fees and paying for insurance, doctoral student Tom Millay takes home about $15,000 per year from a Baylor University stipend. But soon he could be taxed as though he earns three times more.Millay, who is studying religion and works as graduate assistant at Baylor, is one of thousands of doctoral students in Texas and beyond watching nervously as Congressional Republicans iron out the details of their tax cut bill. In exchange for his teaching duties, Millay receives free tuition — a $30,000 savings — and an annual stipend of $20,000. If lawmakers approve the House version of the bill, tuition waivers like his would be marked as taxable income, causing a major financial hit for him and thousands of graduate students like him.The Senate’s version of a tax reform measure does not include the same tax on tuition waivers. The two chambers must reconcile their differences before sending a final version of the bill to President Donald Trump, who has publicly pushed to sign a tax bill by the end of the year.“In terms of net income, [the House proposal] would put most Baylor graduate students right on the poverty line,” said Millay, who acknowledged that his spouse’s income would soften the blow for him. “When your net income at the start is only $15,000, losing additional thousands of dollars each year in taxes is a huge difference.”Universities across Texas and the nation have tried to rally against the proposal. A&M officials said they have “made clear” to lawmakers that the change would have “negative consequences.” Baylor University President Linda Livingstone gently suggested to students and staff that they express their “individual concerns” about the bill. And Rice University president David Leebron called the idea “odious” in a Houston Chronicle op-ed.If the House version of the bill is approved, taxes for some graduate students will increase by as much as 400 percent, according to estimates. Leebron says some of his students could see their tax bills go up five times their current amount. Experts also say the bill may lead to institutions seeing a decline in the number of graduate applicants, which could be devastating to major Texas research schools like Rice and the University of Texas at Austin.“This really affects me because I’m a full-time graduate student,” said Charity Embley, a doctoral student at Texas Tech University. “We’re not independently wealthy.”House tax bill hits higher educationThousands of masters and doctoral students across the country receive tuition waivers in exchange for teaching classes or conducting research. Under current law, those waivers aren’t counted as income. Only the students’ additional stipends, which are usually paltry compared to most full-time jobs, are currently taxed.House lawmakers have said they have moved to eliminate some individual tax breaks like the one for tuition waivers in order to offset the $1.5 trillion tax cuts elsewhere in the bill. But the change would mean that graduate students would be paying taxes on money they never pocket, critics say, and those additional taxes could make earning a graduate degree nearly impossible for some students. “From what I have been hearing as a representative for other graduate students, many live in a precarious financial position,” said Jeff Strietzel, president of the Baylor Graduate Student Association.Strietzel is a third-year doctoral student, a husband and father of four children. In addition to his studies, he works 20-hour weeks and helps run a student organization — all while living under the federal poverty line.“I know that higher education is not the route that every American will take to pursue their version of the ‘American dream,’ but I hope that my representatives have students like me in mind as they consider any reforms to tax policy that makes pursuing higher education in America more difficult,” he said.“We don’t know where we stand”While most expect some form of a tax bill to make its way to Trump soon, it’s still unclear whether the tax on tuition waivers will be included.In recent weeks, several university groups have staged walkouts in response to the House bill. And last week, 31 House Republicans — including six Texans —led by U.S. Rep. Pete Sessions, R-Dallas, wrote a letter urging House and Senate leaders to leave the tuition waiver language out of the final version of the bill.“A tax on graduate tuition waivers would be unfair, would undermine our competitive position, and would inhibit the economic growth that tax reform promises,” the lawmakers wrote. “Repeal of the income exclusion for graduate tuition waivers would subject thousands of graduate students to a major tax increase at a time in their lives when they likely lack the ability to pay.”Nationwide groups representing some of the top research universities in Texas — including Rice, UT-Austin, the University of Houston and Texas A&M University — have come out in opposition of the bill.“As our counterparts and competitors abroad aim to vastly increase the number of skilled workers in highly technical fields, we can’t afford to roll back incentives that have long helped make the American workforce the envy of the world,” said Peter McPherson, president of the Association of Public and Land-grant Universities.Meanwhile, students who would be affected are anxiously watching. “We don’t know where we stand,” said Embley, the Texas Tech graduate student. Share
Source:https://www.upmc.com/media/news/102018-emens-nejm-trial Reviewed by James Ives, M.Psych. (Editor)Oct 23 2018Patients with an aggressive form of advanced breast cancer can benefit from immunotherapy when used in combination with chemotherapy as first-line treatment, according to the results of a large international Phase III clinical trial published today in the New England Journal of Medicine and led by a researcher at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.The study is the first large clinical trial to support the use of immunotherapy in treating triple-negative breast cancer and establishes a new standard of care in PD-L1+ patients, senior trial investigator and study author Leisha Emens, M.D., Ph.D., co-leader of the UPMC Hillman Cancer Immunology and Immunotherapy Program, explained. Results were presented today at the annual meeting of the European Society for Medical Oncology in Munich, Germany.Breast cancer is the most common cancer in women, with an estimated 2 million new cases diagnosed in 2018 alone. About 10 to 20 percent of patients have triple-negative breast cancer, an aggressive form of breast cancer that has a higher chance of recurrence and metastasis, and lower survival.”While chemotherapy is the current standard of treatment for triple-negative breast cancer, there is an urgent need for newer, more effective therapies,” said Emens. “The results of this trial showed that adding the immunotherapy drug atezolizumab to chemotherapy was well-tolerated and resulted in a clear increase in clinical benefit for some patients with triple-negative breast cancer.”The IMpassion130 trial was designed to evaluate whether atezolizumab, approved by the U.S. Food and Drug Administration to treat both bladder cancer and non-small cell lung cancer, could be used along with chemotherapy to improve clinical outcomes in patients with triple-negative breast cancer. Atezolizumab belongs to a class of immunotherapy medications known as checkpoint inhibitors. The drug targets the PD-L1 protein, which in triple-negative breast cancer patients is found mostly on immune cells that infiltrate the tumor. Blocking PD-L1 reinvigorates these immune cells, allowing them to attack the tumor.The trial enrolled 902 patients with either metastatic or locally advanced triple-negative breast cancer that could not be surgically removed. Patients were enrolled at 246 sites in 41 countries across the world and were randomly assigned to receive either atezolizumab or a placebo, along with the chemotherapy drug nab-paclitaxel.Related StoriesUsing machine learning algorithm to accurately diagnose breast cancerLiving with advanced breast cancerAI-enabled device detects if targeted chemotherapy is workingBoth progression-free survival–the length of time the patient lives after receiving the therapy without the tumor growing or spreading, and overall survival–the length of time the patient survives from the start of the trial, were recorded.In the overall patient population, the researchers found a statistically significant increase in progression-free survival in patients treated with both nab-paclitaxel and atezolizumab – 7.2 months when compared to 5.5 months in patients who received chemotherapy alone. In the group of patients who expressed the PD-L1 protein on tumor-infiltrating immune cells, the combination treatment had a more significant impact on progression-free survival – 7.5 months versus 5 months.Overall survival was 21.3 months in the combination treatment group as compared to 17.6 months with chemotherapy alone, though this did not reach statistical significance in this first analysis. In the group of patients who expressed PD-L1 on their tumors, the difference in survival was greater, with overall survival of 25 months, in contrast to 15.5 months in patients treated with nab-paclitaxel alone.”This improvement in progression-free and overall survival is clinically meaningful in patients with advanced PD-L1+ triple-negative breast cancer,” Emens said. The researchers continue to follow the patients to determine overall survival over a longer time period.The adverse events observed were similar to the known adverse event profile of the two drugs. Patients who received both immunotherapy and nab-paclitaxel experienced a higher frequency of adverse events that were potentially immune-related, than those who received chemotherapy alone, at 7.5 percent versus 4.3 percent, respectively.The trial was funded by F. Hoffmann-La Roche/Genentech, which provided atezolizumab and placebo and collaborated with an academic steering committee regarding the trial design and data collection, analysis and interpretation. Celgene provided nab-paclitaxel and had no role in the trial design, data collection or analysis, but did review the manuscript.A complete listing of the authors and their affiliations, along with the financial disclosure forms provided by the authors can be found with the article online.
Reviewed by Alina Shrourou, B.Sc. (Editor)Mar 19 2019A team of researchers across The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing.The Cancer Research UK and Wellcome Trust funded study, published in the journal Cancer Cell, showed that the drugs, called PARG inhibitors, can kill ovarian cancer cells by targeting weaknesses within their ability to copy their DNA.The first-in-class PARG inhibitor PDD00017273, was discovered in the Drug Discovery Unit at the Cancer Research UK Manchester Institute, part of The University of Manchester, as part of a targeted program to discover PARG inhibitors for the clinic.This program is currently being progressed through a collaboration with IDEAYA Biosciences, Inc., an oncology-focused biotechnology company committed to the discovery of breakthrough synthetic lethality medicines and immuno-oncology therapies.Related StoriesTrends in colonoscopy rates not aligned with increase in early onset colorectal cancerNew protein target for deadly ovarian cancerSugary drinks linked to cancer finds studyThese findings are promising for patients diagnosed with ovarian cancer, the sixth commonest cause of cancer in women in the UK and causes more than 4,000 deaths each year.”Sadly, for the majority of women diagnosed with ovarian cancer, the cancer relapses within 12 to 18 months of their first treatment, and so there is a pressing need to develop new therapies to treat this condition” said lead scientist Prof Stephen Taylor from The University of Manchester.Through a collaborative effort across The University of Manchester including the Cancer Research UK Manchester Institute and The Christie , Manchester, scientists were able to screen ovarian cancer cells for specific genes that, when knocked out, would bring about PARG-inhibitor sensitivity. Through their work, the team identified the key genes that made cancer cells sensitive to PDD00017273 were those involved in DNA replication.PhD student Nisha Pillay, provided valuable insight into how PARG inhibitors work. She said: “Before a cell divides, it must replicate its DNA. This critical process ensures the necessary amount of DNA is passed on to its daughter cells. Our research has shown that an inherent defect in the ability of an ovarian cancer cell to replicate its DNA can be exploited by the PARG inhibitor to kill the cancer cell”.”This new class of drugs is potentially very exciting and could signal a new way to help patients diagnosed with ovarian cancer in which their tumor has not responded to standard treatments”.The research team then went on to show that the PARG inhibitor can also be used in combination with other clinically accessible drugs, such as CHK1 and WEE1 inhibitors, to kill ovarian cancer cells that were taken directly from samples from patients treated at The Christie.Dr. Robert Morgan, from The Christie, said: “We hope this work will provide further impetus for developing a PARG inhibitor for use in human trials, and also biomarkers that can be used to select the most appropriate patients to receive such treatments in the future” Source:https://www.manchester.ac.uk/discover/news/new-class-of-drugs-could-treat-ovarian-cancer/
Reporters take pictures of a Nissan Sylphy Zero Emission, the Nissan’s first all-electric vehicle built in China, at the Nissan factory in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) A worker of Dongfeng Nissan, right, wears a uniform with a pin with Chinese words “Communist party member” attends the ceremony of launching Nissan Sylphy Zero Emission, the Nissan’s first all-electric vehicle built in China, in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China, where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) Manufacturers including General Motors and Volkswagen are poised this year to launch a flood of electric sedans, minivans and SUVs in China designed for local tastes and smaller budgets. Nissan, Tesla, GM and others sell imported electrics or electrified versions of models made by Chinese partners, but the market is dominated by low-cost local rivals including BYD Auto.China’s government sees electric cars as a promising industry and a way to clean up its smog choked cities. It has spent heavily on subsidies to Chinese producers and is shifting the burden to automakers with sales quotas and tougher fuel efficiency standards.The Sylphy Zero Emission, based on Nissan’s leaf, is being produced by Nissan Motor Co. and a Chinese partner, Dongfeng Motor group.The Sylphy costs 166,000 yuan ($25,850) after government subsidies, or just over half the sticker price of the Chinese version of the Leaf sold by Nissan and Dongfeng’s joint venture Venucia brand. Nissan says the Sylphy can go 338 kilometers (210 miles) on a charge. Hiroto Saikawa, Nissan Motor Co., Ltd’s president and CEO, right, and Zhu Yanfeng, Chairman and Party Secretary of Dongfeng Motor Group Co., Ltd, left, pose during the launching of the Nissan Sylphy Zero Emission, the Nissan’s first all-electric vehicle built in China, in China, in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China, where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) A worker of Dongfeng Nissan, right, wears a uniform with a pin with Chinese words “Communist party member” attends the ceremony of launching Nissan Sylphy Zero Emission, the Nissan’s first all-electric vehicle built in China, in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China, where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) 5 things to know about Tesla’s China plans Hiroto Saikawa, Nissan Motor Co., Ltd’s president and CEO, right, and Zhu Yanfeng, Chairman and Party Secretary of Dongfeng Motor Group Co., Ltd, left, attend the ceremony of the launching of the Nissan Sylphy Zero Emission, the Nissan’s first all-electric vehicle built in China, in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China, where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) The Chinese government announced in April it would end restrictions on foreign ownership of electric vehicle manufacturers this year in an effort to promote development.Producers including GM and Nissan had been reluctant to transfer manufacturing to China due to the requirement to share technology with Chinese partners that might become rivals.Freed of that requirement, Tesla Inc. announced in July it would build its first factory outside the United States in Shanghai, becoming the first wholly foreign-owned automaker in China.Other automakers are working through ventures with Chinese partners, hoping to take advantage of their experience at developing lower-cost vehicles.Chinese sales in July of pure electric and gasoline-electric hybrids, boosted by subsidies and other government support, rose 47.7 percent over a year to 84,000. © 2018 The Associated Press. All rights reserved. “By the end of this year, things will be different,” said Zhang. “We really will see the market become more competitive and consumers will have more to choose.”Government plans call for total annual sales of 2 million electric and gasoline-electric hybrid vehicles by 2020, up from last year’s 770,000. Workers of the Dongfeng Nissan attend the ceremony launching the Nissan Sylphy Zero Emission, the Nissan’s first all-electric vehicle built in China, in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China, where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) Hiroto Saikawa, Nissan Motor Co., Ltd’s president and CEO, right, and Zhu Yanfeng, Chairman and Party Secretary of Dongfeng Motor Group Co., Ltd, left, attend the ceremony of the launching of the Nissan Sylphy Zero Emission, the Nissan’s first all-electric vehicle built in China, in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China, where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) A cameraman takes video of a Nissan Sylphy Zero Emission, the Nissan’s first all-electric vehicle built in China, at the Nissan factory in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only. GM says it will roll out 10 electric and hybrid models in China from 2016 to 2020. It says 2025, all its Buick, Cadillac and Chevrolet models in China will offer hybrid or pure-electric versions.Tesla says China is its second-largest market. But a high sticker price has limited sales by other foreign brands to a few hundred vehicles. Citation: Nissan launches China-focused electric car (2018, August 27) retrieved 18 July 2019 from https://phys.org/news/2018-08-nissan-china-focused-electric-car.html Nissan’s first electric sedan designed for China began production Monday at the start of a wave of dozens of planned lower-cost electrics being created by global automakers for their biggest market. Chinese workers inspect a Nissan Sylphy Zero Emission, Nissan’s first all-electric vehicle built in China, at a production line in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China, where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) Explore further A worker inspects a Nissan Sylphy Zero Emission, Nissan’s first all-electric vehicle built in China, at a production line in Guangzhou, Guangdong province, China, Monday, Aug. 27, 2018. The Sylphy is part of a wave of dozens of electric models planned by global automakers for China where the government is pressing them to accelerate development of the technology. (AP Photo/Vincent Yu) “We’re confident that the Sylphy Zero Emission rolling off the production line today will become a main player in the EV market,” said Nissan CEO Hiroto Saikawa. “We’re going to roll out a range of EVs that will appeal to customers within all market segments.”Sales quotas that take effect next year require every brand to sell electrics or buy credits from competitors that do. That puts pressure on automakers to create models Chinese consumers want and can afford.China accounted for half of global electric car sales last year, but almost all of those came from Chinese brands including BYD Auto and BAIC Group. Their prices start as low as 140,000 yuan ($22,000).”Basically, all these international giants are testing the water. They have not really launched their heavyweight models in China yet,” said industry analyst Yale Zhang of Automotive Foresight.
Rapid urban population growth is driving many cities around the world to reduce their carbon footprints. In Canada, two major policy agendas are designed to achieve this: boosting urban density and promoting low-carbon transportation such as electric vehicles (EVs). Government incentives could bring more EV charging stations to multi-unit residential buildings. Credit: Shutterstock Despite their overlap, these goals are often pursued separately through disjointed planning strategies. In time, ad-hoc policies could be counterproductive and stall the shift to EVs, by making ownership expensive, inefficient and complicated.Most Canadians live in cities, where the deployment of EVs has two main advantages. First, EVs can drastically reduce local emissions as long as their electricity comes from sustainable sources. Second, their driving ranges are suited to short urban trips. For example, 95 per cent of driving trips in Vancouver are less than 30 kilometres, well within the range of an EV.However, as cities swap single-family homes for multi-unit dwellings to increase population density, reduce housing prices and lower carbon emissions, the installation of EV charging stations in existing multi-unit dwellings is lagging behind. Our research found ways to change that.EV sales on the rise in British ColumbiaBritish Columbia is an attractive location for EVs because roughly 90 per cent of the province’s electricity comes from large renewable hydropower. Widespread EV usage could cut B.C.’s greenhouse gas emissions by up to 98 per cent. Residential electricity rates in B.C. are now low enough that charging a vehicle at home is less expensive than fuelling a conventional gasoline vehicle. Together with B.C.’s EV subsidies, these factors more than doubled provincial EV sales between 2013 and 2017. However, EVs still make up only two per cent of all vehicles on B.C.’s roads. What’s more, B.C.’s current regulations mean that EVs will likely only have a 10 per cent market share by 2040, far below the Canadian government’s goal of 30 per cent by 2030. This suggests more stringent policies are needed. Consumers are switching to EVs as the number of models on the market grows and battery prices decrease, but drivers want to be sure they will be able to charge their vehicles quickly, easily and cheaply. Electrified transportation is still beset by the classic chicken-and-egg problem: fuel providers will not invest in fuelling infrastructure until enough EVs are in circulation, and people will avoid buying an EV until sufficient charging points exist.Few incentives to retrofitWhile a dense network of public charging points will be important for reducing range anxiety among users, almost 90 per cent of charging takes place at home. Yet the installation of home charging stations is complicated in buildings with multiple dwelling units, because of competing interests in the common spaces shared by residents. So-called “Multi-Unit Residential Buildings” now account for over a quarter of all households in B.C. and are forecast to make up 70 per cent of all new residential constructions in the province by 2020.As of 2019, all new multi-family residential developments built in Vancouver must include EV charging infrastructure. But the city has no policies to encourage building owners to retrofit existing buildings with charging points. Our research found financial and technical issues were the most significant barriers to installing charging points in multi-unit residential buildings, mostly due to the imposing electrical loads EV charging stations place on the buildings’ existing power systems. Other barriers include the lack of support from non-EV drivers, unclear regulation concerning the rights and obligations of drivers and landlords, and overly conservative regulatory requirements for buildings.Breaking down barriersMunicipal governments throughout B.C. could break down these barriers with a few key policy changes. B.C. building permits for multiple unit residences are on an upward trend. Credit: Statistics Canada Explore further Provided by The Conversation This article is republished from The Conversation under a Creative Commons license. Read the original article. They could start by introducing financial policies that create incentives for both EV owners and building owners. So-called “demand-focused” policies include programs that provide financial aid to building owners to develop retrofit plans, and to mandate them to retrofit a minimum number of charging stations. EV ownership could be incentivized through rebates that cover the cost of a new vehicle: B.C. already offers rebates of up to $5,000, but this is much lower than in Québec.Municipal governments should also clarify the rights and obligations of builders, building owners, residents and others when it comes to charging infrastructure. For instance, who should pay for the installation and running costs of charging points in condos? What sort of upgrades are needed to deal with the extra electrical loads from EV charging? Non-governmental associations such as the Condominium Home Owners Association of B.C. and the Building Owners and Managers Association of B.C. offer some guidance, but confusion remains.Finally, governments can help raise public awareness and acceptance of EVs by introducing programs to educate people who have less trust in, and understanding of, EV technology.Many municipalities around the world could adopt these suggestions to encourage the installation of at-home EV charging points, while also boosting urban density.Cities generate 80 per cent of global GDP and are responsible for 70 per cent of carbon dioxide emissions, so they are critical arenas for addressing the sources and effects of climate change. As vehicle electrification gains ground in Canada and elsewhere, we will need policies that do a better job of recognizing the obstacles and opportunities around residential charging. The high densification and mobility challenges experienced in B.C.’s urban areas illustrates the challenges faced by many modern cities. NREL evaluates charging infrastructure needs for growing fleet of electric vehicles Apartment buildings and condos often lack charging stations for electric vehicles. Credit: Pixabay Citation: How growing cities can support at-home electric vehicle charging (2019, January 25) retrieved 17 July 2019 from https://phys.org/news/2019-01-cities-at-home-electric-vehicle.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
SHARE SHARE EMAIL December 15, 2018 healthcare industry COMMENTS Published on medical and surgical equipment Radiation hazards in using medical devices, such as x-ray machine, are grossly neglected in the country and most hospitals and diagnostic centres do not comply with the stipulated safety norms, according to Mohammed Amir, a researcher.He was presenting a paper at a session on regulation of medical devices on Saturday, the concluding day, at the three-day WHO Global Forum on Medical Devices at AP Medtech Zone.He said a study conducted in five states had shown that there was very little awareness in the general public as well as professionals in the field about radiation hazards. “No attempt is being made to keep the x-ray machines and other such devices in safe rooms and to train the staff handling them to take precautions to protect themselves as well as the patients. Such devices are being handled casually, exposing people to radiation risks,” he said.However, he said, of late the Government has initiated some steps to sensitise the public as well as the professionals on safety norms. In 10 states, a programme on safety norms has been launched but still a lot remains to be done.Dr V.G Somani, the Joint Drug Controller, India, spoke about the steps being taken to regulate the manufacture, import and marketing of medical devices in the country. On Jan 1, 2018, a notification had been issued under the Drugs and Cosmetics Act, 1940, covering 27 medical devices including BP monitoring equipment. Rules stipulated in the notification were harmonised with the Medical Devices Rules, 2017. Still, the process was going on and many more medical devices would be notified.He said the standards laid down by the Bureau of Indian Standards (BIS) would have to be complied with by the manufacturers, importers and others in the field. If there are no standards by the BIS, then ISO standards would have to be followed. Some of the rules would be enforced by the Centre and some by the States. AMTZ at Visakhapatnam, the first cluster of MD units in the country, would lend support to the regulatory authorities in the country, he added.Dulce Maria Martinez Pereira and Alexandra Lemgruber spoke about the regulatory regime for medical devices in America and Latin America. COMMENT SHARE